ADAR1 Capital Management’s CG Oncology CGON Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.6M | Buy |
523,216
+222,082
| +74% | +$5.77M | 2.09% | 10 |
|
|
2025
Q1 | $7.37M | Buy |
301,134
+85,384
| +40% | +$2.09M | 1.37% | 17 |
|
|
2024
Q4 | $6.19M | Buy |
215,750
+72,646
| +51% | +$2.08M | 1.24% | 17 |
|
|
2024
Q3 | $5.4M | Buy |
143,104
+130,254
| +1,014% | +$4.91M | 0.88% | 27 |
|
|
2024
Q2 | $406K | Buy |
12,850
+10,800
| +527% | +$341K | 0.08% | 102 |
|
|
2024
Q1 | $90K | Buy |
+2,050
| New | +$90K | 0.02% | 142 |
|